BridgeBio Pharma Inc vs Comfort Systems USA Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Comfort Systems USA Inc trades at $1,798.5 (market cap $60.97B). The key difference: Comfort Systems USA Inc is far larger — about 3.7× BridgeBio Pharma Inc's market cap, and Comfort Systems USA Inc pays a 0.15% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | FIX | |
|---|---|---|
Market Cap | $16.27B | $60.97B |
Sector | Health | Technology |
52-Week High | $90.17 | $2.07K |
52-Week Low | $44.81 | $532.14 |
Enterprise Value | $17.82B | $60.26B |
Dividend Yield | — | 0.15% |
Trailing returns across standard periods
Latest headlines on both assets
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →